Maria Nirvana Formiga

Author

Also Known As

Formiga, Maria Nirvana, M. Formiga, M. N. Formiga, Maria Formiga, Maria N. C. Formiga, Maria N. Formiga, Maria N.C. Formiga, Maria Nirvana C. Formiga, Maria Nirvana Cruz Formiga, Maria Nirvana Da Cruz Formiga

Publications

743

Citations

H-Index

Concepts

All Affiliations

AC Camargo Hospital Hospital de Câncer de Barretos City of Hope Hospital Erasto Gaertner The University of Texas MD Anderson Cancer Center

About

Maria Nirvana Formiga is an author at AC Camargo Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	107
2	Pathology	2	2	63
3	Surgical Oncology	2	2	35
4	Health Sciences	1	1	25
5	Immunology	1	1	19

Maria Nirvana Formiga

Publications

506

Citations

H-Index

Page 1

	Year	Citations
The germline mutational landscape of BRCA1 and BRCA2 in Brazil Edenir Inêz Palmero, Dirce Maria Carraro, Bárbara Alemar, Scientific Reports	2018	90
BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation Rafael Canfield Brianese, Kivvi Duarte de Mello Nakamura, Fernanda Gabriella dos Santos Ramos Almeida, Breast Cancer Research and Treatment Recurrent EventBreast OncologySomatic VariantMedicineGenetics	2017	53
XAF1 as a modifier of p53 function and cancer susceptibility Emília M. Pinto, Bonald C. Figueiredo, Wenan Chen, Science Advances	2020	52
Frequency of Thyroid Carcinoma in Brazilian <i>TP53 </i>p.R337H Carriers With Li Fraumeni Syndrome Maria Nirvana Formiga, Kelvin C. de Andrade, Luiz Paulo Kowalski, JAMA Oncology	2017	27
Neoadjuvant hypofractionated radiotherapy and chemotherapy for extremity soft tissue sarcomas: Safety, feasibility, and early oncologic outcomes of a phase 2 trial Maria Letícia Gobo Silva, Celso Abdon Lopes de Mello, Samuel Aguiar, Radiotherapy and Oncology Surgical OncologyRadiation TherapyMedicineOncologic OutcomesCancer Treatment	2021	25
Aortic dissection during antiangiogenic therapy with sunitinib. A case report Maria Nirvana Formiga, Marcello Ferretti Fanelli Sao Paulo Medical Journal	2014	24
High Prevalence of EGFR Mutations in Lung Adenocarcinomas From Brazilian Patients Harboring the TP53 p.R337H Variant Malu Viter R. Barbosa, Vladmir Cláudio Cordeiro de Lima, Maria Nirvana Formiga, Clinical Lung Cancer	2019	24
Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil Deborah Porto Cotrim, Adriana Regina G. Ribeiro, Daniele Paixão, BMC Cancer	2019	23
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09) Nizar M. Tannir, Maria Nirvana Formiga, Konstantin Penkov, Journal of Clinical Oncology	2024	22
Clinical and Molecular Assessment of Patients with Lynch Syndrome and Sarcomas Underpinning the Association with MSH2 Germline Pathogenic Variants Nathália de Angelis de Carvalho, Bianca Naomi Niitsuma, Vanessa Nascimento Kozak, Cancers	2020	20

Page 1